n acetylgalactosaminidase (New England Biolabs)


Structured Review
N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
α n acetylgalactosaminidase (New England Biolabs)


Structured Review
α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
endo α n acetylgalactosaminidase (New England Biolabs)


Structured Review
Endo α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endo α n acetylgalactosaminidase/product/New England Biolabs
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
endo α n acetylgalactosaminidase (New England Biolabs)


Structured Review

Endo α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endo α n acetylgalactosaminidase/product/New England Biolabs
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Expressional Analysis of Immunoglobulin D in Cattle ( Bos taurus ), a Large Domesticated Ungulate"
Article Title: Expressional Analysis of Immunoglobulin D in Cattle ( Bos taurus ), a Large Domesticated Ungulate
Journal: PLoS ONE
doi: 10.1371/journal.pone.0044719

Figure Legend Snippet: (a) Western blot of splenic membrane and serum proteins. (b) Western blot analysis of the IgD glycosylation in bovine serum. 1, Untreated serum proteins; 2, endo-α-N-acetylgalactosaminidase-treated serum proteins; 3, PNGase-treated serum proteins. The primary antibody 13C2 was diluted at 1∶200 or 1∶400. (c) Serum immunoblot analysis with mAb 13C2 and anti-bovine IgM polyclonal antibody under nonreducing conditions. The arrow indicates the monomer of IgD. (d) Immunoblot detection of serum IgD and IgM in differently aged cows. 1, 60 days old; 2, 180 days; 3, 1 year; 4, 2 years; 5, 3 years; 6, 4 years; 7, 5 years; 8, 6 years. The arrows indicate the IgD heavy chain.
Techniques Used: Western Blot
n acetylgalactosaminidase (New England Biolabs)


Structured Review
N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
endo a n acetylgalactosaminidase p0733 (New England Biolabs)


Structured Review
Endo A N Acetylgalactosaminidase P0733, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endo a n acetylgalactosaminidase p0733/product/New England Biolabs
Average 96 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
α n acetylgalactosaminidase (New England Biolabs)


Structured Review
![Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N <t>-acetylgalactosaminidase.</t> At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A pain-causing and paralytic ant venom glycopeptide"
Article Title: A pain-causing and paralytic ant venom glycopeptide
Journal: iScience
doi: 10.1016/j.isci.2021.103175
![... and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide ... Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
Figure Legend Snippet: Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).
Techniques Used: Solubility, Purification, Concentration Assay, Microscopy, Activity Assay

Figure Legend Snippet:
Techniques Used: Recombinant, Software
p0734s (New England Biolabs)


Structured Review

P0734s, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p0734s/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A pain-causing and paralytic ant venom glycopeptide"
Article Title: A pain-causing and paralytic ant venom glycopeptide
Journal: iScience
doi: 10.1016/j.isci.2021.103175

Figure Legend Snippet:
Techniques Used: Recombinant, Software
α n acetylgalactosaminidase (New England Biolabs)


Structured Review
![Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N <t>-acetylgalactosaminidase.</t> At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A pain-causing and paralytic ant venom glycopeptide"
Article Title: A pain-causing and paralytic ant venom glycopeptide
Journal: iScience
doi: 10.1016/j.isci.2021.103175
![... and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide ... Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
Figure Legend Snippet: Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).
Techniques Used: Solubility, Purification, Concentration Assay, Microscopy, Activity Assay

Figure Legend Snippet:
Techniques Used: Recombinant, Software
α n acetylgalactosaminidase (New England Biolabs)


Structured Review
![Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N <t>-acetylgalactosaminidase.</t> At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
α N Acetylgalactosaminidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α n acetylgalactosaminidase/product/New England Biolabs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A pain-causing and paralytic ant venom glycopeptide"
Article Title: A pain-causing and paralytic ant venom glycopeptide
Journal: iScience
doi: 10.1016/j.isci.2021.103175
![... and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide ... Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7206/pmc08517206/pmc08517206__gr6.jpg)
Figure Legend Snippet: Glycosylation is critical to maintaining the aqueous solubility of Mg7a (A) Enzymatic deglycosylation of Mg7a. Time-course of deglycosylation of Mg7a, as measured by relative ion count of glycoforms at 1, 2 and 4 h of treatment with α- N -acetylgalactosaminidase. At 1 h, only 2% of detected peptide was still fully glycosylated, while 91% was fully deglycosylated and 7% was partially deglycosylated (i.e., Mg7a with the loss of 2 GalNAc moieties). At 2 h, no fully glycosylated peptide was detected, and 94% was fully deglycosylated. (B) Purification of deglyco-Mg7a by HPLC on a Gemini NX-C18 column (250 × 4.6 mm; particle size, 3 μm; pore size, 110 Å; Phenomenex) using a gradient of 5 to 50% solvent B (90% MeCN and 0.05% TFA) over 45 min at a flow rate of 1 mL/min. Mass of eluting peaks was confirmed by MALDI-MS (linear mode). Theoretical monoisotopic [M+1H] 1+ of Mg7a (loss of 2 GalNAc) = m/z 6705; Mg7a (loss of 3 GalNAc) = m/z 6503. Trace from Mg7a (fully glycosylated), run under the same conditions, is shown for comparison. (C) Fibrillar precipitate formed upon reconstitution of deglycosylated Mg7a in water at a concentration of ∼100 μM. Image was acquired on a Nikon DS-Qi2 microscope; scale bar = 100 μm. (D) Activity of Mg7a and analogs on F11 cells. Data are expressed as mean ± SEM ( n = 3).
Techniques Used: Solubility, Purification, Concentration Assay, Microscopy, Activity Assay

Figure Legend Snippet:
Techniques Used: Recombinant, Software
endo α n acetylgalactosaminidase o glycosidase (New England Biolabs)


Structured Review
Endo α N Acetylgalactosaminidase O Glycosidase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endo α n acetylgalactosaminidase o glycosidase/product/New England Biolabs
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99